Stocks and Investing
Stocks and Investing
Wed, August 5, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Raghuram Selvaraju Maintained (CDNA) at Strong Buy with Increased Target to $40 on, Aug 5th, 2020
Raghuram Selvaraju of HC Wainwright & Co., Maintained "CareDx, Inc" (CDNA) at Strong Buy with Increased Target from $37 to $40 on, Aug 5th, 2020.
Raghuram has made no other calls on CDNA in the last 4 months.
There are 2 other peers that have a rating on CDNA. Out of the 2 peers that are also analyzing CDNA, 0 agree with Raghuram's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Raghuram
- Sung Ji Nam of "BTIG" Initiated at Strong Buy and Held Target at $40 on, Friday, June 26th, 2020
- Yi Chen of "HC Wainwright & Co." Reiterated at Strong Buy with Decreased Target to $40 on, Friday, May 1st, 2020